SCHEMBL23919165

SCHEMBL23919165

O=C1CCC(N2Cc3ccccc3C2)C(=O)N1Cc1ccccc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 1/20 0.54
POLB P06746 1/20 0.51
CRBN Q96SW2 1/20 0.47
ALDH1A1 P00352 6/20 0.47
MT-CO2 P00403 2/20 0.46
ALOX5 P09917 2/20 0.46
GAA P10253 2/20 0.45
HPGD P15428 3/20 0.45
CYP1A2 P05177 1/20 0.45
CYP3A4 P08684 1/20 0.45
CYP2C9 P11712 1/20 0.45
CYP2C19 P33261 1/20 0.45
STAT6 P42226 1/20 0.45
ME1 P48163 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
HDAC6 Q9UBN7 2/20 0.43
HDAC4 P56524 1/20 0.43
HDAC1 Q13547 1/20 0.43
HDAC7 Q8WUI4 1/20 0.43
HDAC2 Q92769 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20128652 0.81 CRBN (0.52) ADORA2APOLBCRBNALDH1A1MT-CO2
SCHEMBL22426224 0.80 ALDH1A1 (0.57) ADORA2APOLBALDH1A1GAAHPGD
SCHEMBL22426225 0.80 ALDH1A1 (0.57) ADORA2APOLBALDH1A1GAAHPGD
SCHEMBL23968261 0.80 ADORA2A (0.45) ADORA2APOLBALDH1A1MT-CO2ALOX5
SCHEMBL4120260 0.78 ALDH1A1 (0.50) POLBCRBNALDH1A1MT-CO2ALOX5
SCHEMBL17169711 0.77 ALDH1A1 (0.60) ADORA2APOLBALDH1A1MT-CO2ALOX5
SCHEMBL20128666 0.77 ALDH1A1 (0.50) ADORA2APOLBALDH1A1MT-CO2ALOX5
SCHEMBL24787870 0.75 CRBN (0.53) CRBNALDH1A1CYP3A4MEN1KMT2A
SCHEMBL31274976 0.75 MT-CO2 (0.54) POLBALDH1A1MT-CO2ALOX5GAA
SCHEMBL16446966 0.75 KMT2A (0.57) POLBALDH1A1MT-CO2ALOX5GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210315896-A1 INDAZOLE BASED COMPOUNDS AND ASSOCIATED METHODS OF USE ARVINAS OPERATIONS, INC. 2021-10-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210315896-A1 INDAZOLE BASED COMPOUNDS AND ASSOCIATED METHODS OF USE LRRK2, CRBN, MDM2 ADORA2A 2797/4885POLB 3660/4885CRBN 2/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.